Concepedia

Lars Toleikis

LT

Statistics

Publications

24

Citations

1.1K

H-Index

20

Active since

2004

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Technische Universität Darmstadt

Ono Pharmaceutical (United States)

Technische Universität Braunschweig

Merck Serono S.p.A. (Italy)

Lars Toleikis is an author at Merck KGaA, Darmstadt (Germany) specializing in antibody engineering, pharmacy, and immunology.

Publications per year

2004–2024

24

Publications

24

Bi-specific Aptamers Mediating Tumor Cell Lysis

Achim Boltz, Birgit Piater, Lars Toleikis et al. · Journal of Biological Chemistry · 2011 · 161 citations · Full text

, , +17

Generation and analysis of the improved human HAL9/10 antibody phage display libraries

Jonas Kügler, Sonja Wilke, Doris Meier et al. · BMC Biotechnology · 2015 · 130 citations · Full text

, , +17

Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates

Carolin Sellmann, Achim Doerner, Christine Knuehl et al. · Journal of Biological Chemistry · 2016 · 91 citations · Full text

, , +17

Rise and Fall of an Anti-MUC1 Specific Antibody

Holger Thie, Lars Toleikis, Jiandong Li et al. · PLoS ONE · 2011 · 79 citations · Full text

, , +17

A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display

Christian Schröter, Ralf Günther, Laura Rhiel et al. · mAbs · 2014 · 78 citations · Full text

, , +17

1–5 of 24